What's on this Page
Benoxinate Fluorescein Brand Names
Fluorbenox | Fluorox | Flurate | Fluress | Flurox
What is Benoxinate Fluorescein
Benoxinate fluorescein is an ophthalmic solution indicated for use in adults and pediatric patients undergoing an ophthalmic procedure that requires a disclosing agent and topical anesthesia.
Benoxinate is a local anesthetic agent and fluorescein is a fluorescent dye that is used as a diagnostic aid.
The solution is administered topically to the eye by a healthcare professional; after which, corneal anesthesia usually occurs in about 5 to 45 seconds and lasts for approximately 20 minutes.
Subsequent doses may be administered as needed every 10 to 20 minutes. Instruct patients not to touch their eyes while the eye is insensitive (approximately 20 minutes after drug application) in order to avoid accidental ocular injury.
Indications
- ophthalmic anesthesia
For use in ophthalmic procedures requiring a disclosing agent and local ophthalmic anesthesia
Side Effects
- blurred vision
- conjunctival hyperemia
- keratitis
- ocular irritation
- ocular pain
- visual impairment
Prolonged use of topical ophthalmic anesthetics, such as benoxinate; fluorescein, can cause corneal epithelial toxicity which may progress to permanent corneal damage with accompanying visual loss (visual impairment).
Other ocular adverse events associated with the administration of benoxinate; fluorescein include ocular or conjunctival hyperemia, ocular irritation (stinging), ocular pain (burning), blurred vision, and punctate keratitis.
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- breast-feeding
- ocular trauma
- pregnancy
- visual disturbance
Interactions
There are no drug interactions associated with Benoxinate; Fluorescein products.